Literature DB >> 17390294

Exploring proteasome complexes by proteomic approaches.

Oliver Drews1, Chenggong Zong, Peipei Ping.   

Abstract

The ubiquitin proteasome system (UPS) represents a major pathway for intracellular protein degradation. Proteasome dependent protein quality control participates in cell cycle, immune response and apoptosis. Therefore, the UPS is in focus of therapeutic investigations and the development of pharmaceutical agents. Detailed analyses on proteasome structure and function are the foundation for drug development and clinical studies. Proteomic approaches contributed significantly to our current knowledge in proteasome research. In particular, 2-DE has been essential in facilitating the development of current models on molecular composition and assembly of proteasome complexes. Furthermore, developments in MS enabled identification of UPS proteins and their PTMs at high accuracy and high-throughput. First results on global characterization of the UPS are also available. Although the UPS has been intensively investigated within the last two decades, its functional significance and contribution to the regulation of cell and tissue phenotypes remain to be explored. This review recapitulates a variety of applied proteomic approaches in proteasome exploration, and presents an overview of current technologies and their potential in driving further investigations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17390294     DOI: 10.1002/pmic.200600574

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  20 in total

Review 1.  Proteasome inhibitors and cardiac cell growth.

Authors:  Nadia Hedhli; Christophe Depre
Journal:  Cardiovasc Res       Date:  2009-07-03       Impact factor: 10.787

Review 2.  Protein quality control and degradation in cardiomyocytes.

Authors:  Xuejun Wang; Huabo Su; Mark J Ranek
Journal:  J Mol Cell Cardiol       Date:  2008-05-20       Impact factor: 5.000

3.  Revealing the dynamics of the 20 S proteasome phosphoproteome: a combined CID and electron transfer dissociation approach.

Authors:  Haojie Lu; Chenggong Zong; Yueju Wang; Glen W Young; Ning Deng; Pete Souda; Xiaohai Li; Julian Whitelegge; Oliver Drews; Peng-Yuan Yang; Peipei Ping
Journal:  Mol Cell Proteomics       Date:  2008-06-25       Impact factor: 5.911

Review 4.  The ubiquitin-proteasome system in myocardial ischaemia and preconditioning.

Authors:  Saul R Powell; Andras Divald
Journal:  Cardiovasc Res       Date:  2009-09-30       Impact factor: 10.787

Review 5.  Proteasome functional insufficiency in cardiac pathogenesis.

Authors:  Xuejun Wang; Jie Li; Hanqiao Zheng; Huabo Su; Saul R Powell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-23       Impact factor: 4.733

Review 6.  Characterizing the dynamics of proteasome complexes by proteomics approaches.

Authors:  Robyn M Kaake; Athit Kao; Clinton Yu; Lan Huang
Journal:  Antioxid Redox Signal       Date:  2014-03-27       Impact factor: 8.401

Review 7.  The ubiquitin proteasome system and myocardial ischemia.

Authors:  Justine Calise; Saul R Powell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-07       Impact factor: 4.733

8.  Molecular mechanisms of proteasome plasticity in aging.

Authors:  Karl A Rodriguez; Maria Gaczynska; Pawel A Osmulski
Journal:  Mech Ageing Dev       Date:  2010-01-18       Impact factor: 5.432

9.  Structure of Rpn10 and its interactions with polyubiquitin chains and the proteasome subunit Rpn12.

Authors:  Christiane Riedinger; Jonas Boehringer; Jean-Francois Trempe; Edward D Lowe; Nicholas R Brown; Kalle Gehring; Martin E M Noble; Colin Gordon; Jane A Endicott
Journal:  J Biol Chem       Date:  2010-08-24       Impact factor: 5.157

10.  Gel-based chemical cross-linking analysis of 20S proteasome subunit-subunit interactions in breast cancer.

Authors:  Hai Song; Hua Xiong; Jing Che; Qing-Song Xi; Liu Huang; Hui-Hua Xiong; Peng Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.